Now accepting Scholarship Applications. All applications must be post marked by April 5, 2019.
Mainstreet Drugs, Inc Logo

Get Healthy!

Results for search "Multiple Sclerosis".

02 Jul

Multiple Sclerosis and Cancer Risk

MS patients may have a higher risk of developing certain cancers.

Health News Results - 40

WEDNESDAY, Aug. 28, 2019 (HealthDay News) -- If you have multiple sclerosis (MS), you can and should receive recommended vaccinations -- including annual flu shots, a new American Academy of Neurology guideline says.

"We reviewed all of the available evidence, and for people with MS, preventing infections through vaccine use is a key part of medical care," said guideline lead author D...

WEDNESDAY, Aug. 28, 2019 (HealthDay News) -- Medicare patients with multiple sclerosis (MS) saw their medication costs soar by more than sevenfold over a decade, a new study finds.

It's no secret that the costs of MS drugs have skyrocketed in recent years. When the first so-called disease-modifying drugs were approved starting in the 1990s, they cost roughly $8,000 to $11,000 per year...

TUESDAY, Aug. 13, 2019 (HealthDay News) -- "Smoldering" spots in the brains of multiple sclerosis patients may signal more aggressive and disabling forms of the disease, researchers report.

Their finding may help test the effectiveness of new treatments for these types of MS.

The investigators used specialized brain scans to examine the brains of hundreds of MS patients and ...

FRIDAY, July 26, 2019 (HealthDay News) -- Surgery is safe for people with multiple sclerosis (MS), a new study finds.

"The idea that patients with MS might be at an increased risk of relapse following surgery isn't necessarily the case, so we need to be careful delaying important surgeries," said study first author Dr. Lindsey De Lott. She is an assistant professor of neurology at the...

TUESDAY, July 16, 2019 (HealthDay News) -- Obese children may be twice as likely to develop multiple sclerosis, a new study suggests.

And once obese children are diagnosed, they tend to have a poorer response to their initial treatment than average-weight kids do.

Multiple sclerosis (MS) is a neurological disorder caused by a misguided immune system attack on the body's myel...

MONDAY, July 1, 2019 (HealthDay News) -- Multiple sclerosis is a tough disease to manage and live with, but a new, long-running Norwegian study suggests it might also raise cancer risk.

Overall, the higher risk was small -- just 12%. However, the risk of certain cancers -- such as central nervous system (brain, spinal cord and optic nerve) cancers and urinary cancers were around ...

WEDNESDAY, June 12, 2019 (HealthDay News) -- Obesity can worsen multiple sclerosis symptoms, researchers say.

Their study involved 140 patients with the relapsing-remitting form of MS, which means patients have periods of attacks (relapses), followed by periods of remission with no or few symptoms. The researchers found that obesity at the time of diagnosis was associated with more s...

WEDNESDAY, May 1, 2019 (HealthDay News) -- Multiple sclerosis, epilepsy and Parkinson's can be physically taxing conditions, but new research shows they exact a huge financial toll as well.

Over a 12-year period, out-of-pocket costs for Americans with these illnesses jumped, with the biggest increase seen among people with multiple sclerosis (MS). Those patients paid 20 times more fo...

THURSDAY, April 11, 2019 (HealthDay News) -- Almost one in five multiple sclerosis patients may be misdiagnosed with the autoimmune disease, according to a new study.

Of 241 previously diagnosed multiple sclerosis (MS) patients referred to two major Los Angeles medical centers for treatment, nearly 18% did not actually have the autoimmune disease, the researchers found.

...

MONDAY, April 1, 2019 (HealthDay News) -- The U.S. Food and Drug Administration has approved another new multiple sclerosis drug -- the second in one week.

Mavenclad (cladribine) pills can be used to treat relapsing forms of MS in adults, including relapsing-remitting disease and active secondary progressive disease. The drug is not recommended for MS patients with a course of the dis...

THURSDAY, March 28, 2019 (HealthDay News) -- An older but still common multiple sclerosis (MS) treatment has an unexpected perk: It not only quells symptoms, but patients may also live longer.

New research revealed that patients taking a beta interferon drug for more than three years were likely to live longer than those who took one for a shorter time or who didn't take one at all. <...

WEDNESDAY, March 27, 2019 (HealthDay News) -- A new pill for relapsing forms of multiple sclerosis (MS) has won approval from the U.S. Food and Drug Administration.

Generally, relapsing MS involves periods of worsening symptoms followed by recovery periods. Over time, some disability follows independent of relapses, and this is called secondary progressive multiple sclerosis, or SPMS....

FRIDAY, March 22, 2019 (HealthDay News) -- Proper treatment can help people with multiple sclerosis (MS) contend with their disease, an expert says.

"Patients get a predisposed feeling that their life is doomed. That it's going to be a complicated life, which isn't necessarily so," said Dr. Cary Twyman, a neurologist at Penn State Health.

"There are many misconceptions and f...

WEDNESDAY, March 20, 2019 (HealthDay News) -- Research has suggested that kids who enter puberty early appear to face an increased risk of developing multiple sclerosis (MS) as adults.

But a new study asserts that it's actually the excess weight these kids carry around that might raise their odds for MS.

"Although we did see that people who enter puberty at an earlier age we...

THURSDAY, March 7, 2019 (HealthDay News) -- A new study challenges the long-held belief that multiple sclerosis (MS) can flare up right after pregnancy in women with the relapsing-remitting form of the disease.

In that type of MS, symptoms arise, then go into periods of remission.

"These results are exciting, as MS is more common among women of childbearing age than in any o...

TUESDAY, March 5, 2019 (HealthDay News) -- Popping open too many sodas or other sweetened beverages each day might worsen symptoms for people with multiple sclerosis, new research suggests.

It's important to note that the small study could only point to an association -- it couldn't prove that high soda intake causes MS symptoms to get worse.

But study author Dr. Elisa Meier...

TUESDAY, March 5, 2019 (HealthDay News) -- Fatigue can plague many people with multiple sclerosis (MS). But a small new study suggests a soothing cup of hot cocoa may bring some relief.

Like dark chocolate, cocoa is rich in flavonoids, which are abundant in fruit and vegetables and have been linked with anti-inflammatory properties, explained researcher Shelly Coe, of the Center for ...

WEDNESDAY, Feb. 6, 2019 (HealthDay News) -- Medicare rule changes could trigger a spike in out-of-pocket drug costs for patients with multiple sclerosis (MS).

Due to rules that restrict access and require patients to cover more of the cost, those without low-income subsidies can expect to spend almost $6,900 a year out of pocket for MS medicines, researchers reported.

"It's ...

TUESDAY, Jan. 15, 2019 (HealthDay News) -- A stem cell transplant may help some people with multiple sclerosis (MS) when standard drugs fail, a new clinical trial finds.

The study focused on 110 patients with aggressive cases of MS: Their symptoms had flared up at least twice in the past year despite taking standard medication, and they'd already tried an average of three of those dru...

WEDNESDAY, Jan. 9, 2019 (HealthDay News) -- An immune system drug may help prevent or slow complications in a type of multiple sclerosis known as secondary progressive MS, a new study finds.

The medication is called rituximab (Rituxan). It's used to treat a number of conditions, including certain blood cell cancers and the autoimmune condition rheumatoid arthritis.

The ...

WEDNESDAY, Dec. 19, 2018 (HealthDay News) -- Researchers say they've identified a potential link between food allergies and flare-ups of multiple sclerosis.

"Our findings suggest that MS patients with allergies have more active disease than those without, and that this effect is driven by food allergies," said study author Dr. Tanuja Chitnis, an MS specialist, and colleagues.

...

WEDNESDAY, Dec. 5, 2018 (HealthDay News) -- A new warning has been added to the multiple sclerosis drug Lemtrada (alemtuzumab) after rare reports of patients suffering strokes and tears in the lining of the arteries in the head and neck, the U.S. Food and Drug Administration said.

Most patients with these problems -- which can lead to permanent disability and death -- developed sympto...

TUESDAY, Nov. 27, 2018 (HealthDay News) -- Although the findings are so far only in mice, studies suggest that aspirin -- even the "low-dose" variety -- might help counter multiple sclerosis.

Multiple sclerosis (MS) is an autoimmune disorder where aberrant immune system T-cells attack and destroy the protective myelin protein sheath that coats nerves.

This causes gradual deb...

FRIDAY, Oct. 12, 2018 (HealthDay News) -- Medical products derived from marijuana might have a mild benefit in treating symptoms of multiple sclerosis, based on reports from patients.

Drugs containing the major chemical compounds in cannabis are associated with a limited and mild reduction in muscle contractions, bladder dysfunction and pain, based on patient self-assessments from cli...

FRIDAY, Sept. 28, 2018 (HealthDay News) -- Living with a potentially disabling condition like multiple sclerosis (MS) can be difficult, but new research suggests patients get better at dealing with it over time.

"There's an aging paradox in healthy adults. We expect people who are older to be more depressed and anxious because of aging processes [such as physical aches and pain and l...

WEDNESDAY, Sept. 12, 2018 (HealthDay News) -- Researchers say the first drug for children with multiple sclerosis vastly outperformed another common MS medication in a new clinical trial.

Fingolimod (Gilenya) reduced relapse rates by 82 percent in patients aged 10 to 17 compared with interferon beta-1a, a drug commonly used to slow the progression of the degenerative nerve disease.

WEDNESDAY, Aug. 29, 2018 (HealthDay News) -- A drug that has long been used in Japan for asthma may slow down brain shrinkage in people with progressive multiple sclerosis, a preliminary trial has found.

The study, published Aug. 30 in the New England Journal of Medicine, tested an oral drug called ibudilast. It is not approved in the United States, but has been used for years ...

THURSDAY, Aug. 23, 2018 (HealthDay News) -- A new subtype of multiple sclerosis (MS) has been identified by researchers, and the discovery changes understanding of the disease.

MS has long been considered a disease of the brain's white matter, where immune cells destroy the fatty protective covering (myelin) on nerve cells. The destruction of myelin (demyelination) is linked to nerve...

WEDNESDAY, July 18, 2018 (HealthDay News) -- Pain, sleep problems and mental health disorders are common in the five years before someone is diagnosed with multiple sclerosis, a new study reveals.

Knowing about these symptoms could help doctors diagnose and start treating MS earlier, possibly slowing the damage it causes to the brain and spinal cord, says a Canadian team of researcher...

TUESDAY, July 17, 2018 (HealthDay News) -- People with multiple sclerosis (MS) often live with uncertainty because it's hard to predict how quickly the disease will progress and how disabling it might become.

But researchers hope a new MRI test that tracks iron levels in the brain will help answer those questions.

The test -- called quantitative susceptibility mapping (QSM)...

MONDAY, July 16, 2018 (HealthDay News) -- Vitamin D does little to defend your brain against multiple sclerosis, Parkinson's disease or Alzheimer's disease, a new review shows.

The finding is based on an analysis of more than 70 studies.

"Our work counters an emerging belief held in some quarters suggesting that higher levels of vitamin D can impact positively on brain heal...

TUESDAY, July 3, 2018 (HealthDay News) -- A triple whammy of genetics, smoking, and exposure to paints and solvents at work puts a person at extremely high risk of developing multiple sclerosis, Swedish researchers report.

On its own, any one factor elevates the risk for the central nervous system disease substantially, the investigators said. But when all three factors line up, the r...

MONDAY, April 23, 2018 (HealthDay News) -- Most multiple sclerosis patients shouldn't wait to start taking medication in the early stages of the disease, new guidelines say.

"The treatment landscape for people with MS has changed dramatically over the last decade," said lead guidelines author Dr. Alexander Rae-Grant, who's with the Cleveland Clinic.

"We now have a number of ...

MONDAY, April 16, 2018 (HealthDay News) -- Millions of young Americans have lived through the fatigue and discomfort of mononucleosis.

Now, new research suggests, but doesn't prove, that the virus that causes the illness may be linked to an increased risk for seven other serious immune-system diseases.

Those diseases include lupus; multiple sclerosis; rheumatoid arthritis; j...

WEDNESDAY, March 7, 2018 (HealthDay News) -- Living in sunnier climes when young might help shield you from multiple sclerosis decades later, new research suggests.

The main factor may be the sun's ultraviolet B (UV-B) rays, which help the body produce vitamin D, according to a Canadian team. They noted that lower levels of vitamin D have been associated with a rise in risk for multip...

THURSDAY, March 1, 2018 (HealthDay News) -- People who eat fish regularly seem to have a lower risk of developing multiple sclerosis, researchers report.

How much fish makes a difference? In this study, people who ate fish at least once a week -- or who ate fish one to three times a month and took daily fish oil supplements -- had a 45 percent lower risk of developing multiple sclero...

THURSDAY, Feb. 8, 2018 (HealthDay News) -- A powerful multiple sclerosis drug presents women with a tough dilemma if they would like to have children, a pair of new studies suggests.

Those who take Tysabri (natalizumab) to manage their MS are more likely to suffer a relapse during pregnancy if they stop taking the drug before they conceive, the first study found.

But if a wo...

WEDNESDAY, Jan. 31, 2018 (HealthDay News) -- Problems with balance are a common hallmark of multiple sclerosis, but new research suggests a specially designed exercise program can help put patients on firmer ground.

People with MS who enrolled in the 14-week program showed "greater improvements in balance, dizziness and fatigue," compared to MS patients who hadn't done the exercises. ...

WEDNESDAY, Dec. 6, 2017 (HealthDay News) -- The old adage that "an apple a day keeps the doctor away" appears to be at least partly true for people living with multiple sclerosis (MS).

New research suggests that a healthy diet -- one that's chock-full of fruits, vegetables and whole grains but contains little added sugars and red or processed meats -- was associated with a reduced ri...

MONDAY, Nov. 27, 2017 (HealthDay News) -- The main proponent of a controversial treatment for multiple sclerosis now has declared the therapy to be worthless.

For nearly a decade, Italian researcher Dr. Paolo Zamboni investigated inadequate blood flow as a potential cause of MS and has promoted reopening the veins that serve the central nervous system as a possible means of treating t...

Show All Health News Results